In the build-up to the second annual AI in Pharma Summit 2018 (Oct 9th, Boston, MA), I caught up with Chantelle Kiernan from Nuritas to hear her insights on the crucial barriers and opportunities facing the application of AI in Pharma.
With a broad experience across life sciences, particularly focused on collaborations, Chantelle provides a unique perspective on the industry.
Dr. Chantelle Kiernan joined Nuritas in 2018 as Director of Life Sciences having spent almost 18 years working across a variety of Life Sciences sectors. In her last role as Senior Scientific Advisor for IDA, she was integral in securing multi-million strategic research investments for Ireland from the world’s largest Biologics, Pharmaceutical and Medical Device multinationals. In her current role, she seeks to continue her collaboration with large Pharma, with an objective to accelerate the practical adoption of AI to facilitate industry in their discovery of novel bioactive therapeutics.